Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast

British Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 788-794

  Gandhi, A ^a   Holland, P A ^a   Knox, W F ^a   Potten, C S ^a,b   Bundred, N J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; Comedo necrosis; Ductal carcinoma in situ

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROTEIN BCL 2;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CARCINOMA IN SITU; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSCOPY; MITOSIS INDEX; ONCOGENE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0031702816     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.580     Document Type: Article

References (41)

1. Allan AJ, Howell A, Roberts SA, Williams GT, Watson RJ, Coyne JD, Clarke RB, Laidlaw IJ and Potten CS (1992) Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol 167: 25-32
2. Barnes DM, Meyer JS, Gonzales JG, Gullick WJ and Millis RR (1991) Relationship between c-erbB-2 and thymidine labelling index in breast carcinoma in situ. Breast Cancer Res Treat 18: 11-17
3. Bellamy COC, McDonald C, Salter DM, Chetty U and Anderson TJ (1993) Noninvasive ductal carcinoma of the breast, the relevance of histologic categorisation. Hum Pathol 24: 16-23
4. Bissonette RP, Echeverri F, Mahboubi A and Green DR (1992) Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359: 552-554
5. Bodis S, Siziopikou KP, Schnitt SJ, Harris JR and Fisher DE (1996) Extensive apoptosis in ductal carcinoma in situ of the breast. Cancer 77: 1831-1835
6. Carson DA and Ribeiro JM (1993) Apoptosis and disease. Lancet 341: 1251-1254
7. Deshane J, Loechel F, Conry RM, Siegal GP, King CR and Curiel DT (1994) Intracellular single-chain antibody directed against erbB-2 down-regulates cell surface erbB-2 and exhibits a selective anti-proliferative effect in erbB-2 overexpressing cancer cell lines. Gene Ther 1: 332-337
8. Deshane J, Grim J, Loechel S, Siegal GP, Alvarez RD and Curiel DT (1996) Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis. Cancer Gene Ther 32: 89-98
9. Douglas-Jones AG, Gupta SK, Attanoos RL, Morgan JM and Mansel RE (1996) A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma. Histopathology 29: 397-409
10. Ernster VL, Barclay J, Kerlkowska K, Grady D and Henderson C (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275: 913-918
11. Fanidi A, Harrington EA and Evans GI (1992) Co-operative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554-556
12. Ferguson DJP and Anderson TJ (1981) Morphological evaluation of cell turnover in relation to the menstrual cycle in the 'resting' human breast. Br J Cancer 44: 177-181
13. Fisher ER, Costantino J, Fisher B, Paleker AS, Redmond C and Mamounas E (1995) Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17, intraductal carcinoma (ductal carcinoma in situ). Cancer 75: 1310-1319
14. Gee JMW, Robertson JFR, Ellis IO, Willsher P, McClelland RA, Holye HB, Kyme SR, Finlay P, Blamey RW and Nicholson RI (1994) Immunocytochemical localisation of bcl-2 protein an human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int J Cancer 59: 619-628
15. Gupta SK, Douglas-Jones AG, Jasani B, Morgan JM, Pignatelli M and Mansel RE. (1997). E-Cadherin (E-cad) expression in ductal carcinoma in situ (DCIS) of the breast. Virchows Arch 430: 23-28
16. Harris RA, Hiles ID, Page MJ and O'Hare MJ (1995) The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. Br J Cancer 72: 386-392
17. Hockenbery D, Nunez G, Milliman C, Schreiber RD and Korsemeyer SJ (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336
18. Hockenbery DM, Zutler M, Hickey W, Nahm M and Korsmeyer SJ (1991) Bcl-2 protein is topographically restricted in tissues characterised by apoptotic cell death. Proc Natl Acad Sci USA 88: 6961-6965
19. Holland PA, Knox WF, Potten CS, Howell A, Anderson E, Baildam AD and Bundred NJ (1997) Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst 89: 1059-1065
20. Holland R, Hendriks JHLL, Verbeek ALM, Mravunac M and Schuurmans-Stekhoven JH (1990) Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335: 519-522
21. Johnston SRD, Maclennan KA, Sacks NPM, Salter J, Smith IE and Dowsett M (1994) Modulation of bcl-2 and Ki67 expression in oestrogen receptor-positive human breast cancer by Tamoxifen. Eur J Cancer 30A: 1663-1669
22. Kerr JFR, Winterford CM and Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73: 2013-2126
23. Lagios MD (1990) Ductal carcinoma in situ. Pathology and treatment. Surg Clin North Am 70: 853-871
24. Leek RD, Kaklamanis L, Pezzella F, Gatter K and Harris AL (1994) bcl-2 in normal human breast and carcinoma, association with oestrogen-receptor positive. epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69: 135-139
25. Lipponen P, Aaltomaa S, Kosma VM and Syrjänen K (1994) Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30A: 2068-2073
26. Merritt AJ, Potten CS, Watson AJM, Loh DY, Nakayama K, Nakayama K and Hickman JA (1995) Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 108: 2261-2271
27. Page DL and Lagios MD (1995) Pathological analysis of the NSABP-B17 trial. Cancer 75: 1219-1222
28. Page DL, Dupont WD, Rogers LW and Landenberger M (1982) Intraductal carcinoma if the breast: follow-up after biopsy only. Cancer 4: 751-758
29. Page DL, Anderson TJ and Rogers LW (1989) Carcinoma in situ. In Diagnostic Histopathology of the Breast. Page DL, Anderson TJ (eds) pp. 43-61 Edinburgh: Churchill Livingstone
30. Potten CS (1992) The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metastasis Rev 11: 179-195
31. Potten CS (1996) What is apoptotic index measuring? A commentary. Br J Cancer 74: 1743-1748
32. Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M and Howell A (1988) The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br J Cancer 58: 163-170
33. Sabourin JC, Martin A, Baruch J, Truc JB, Gompel A and Poitout P (1994) bcl-2 expression in normal breast tissue during the menstrual cycle. Int J Cancer 59: 1-6
34. Schwartzman RA and Cidlowski JA (1993) Apoptosis, the biochemistry and molecular biology of programmed cell death. Endocr Rev 14(2): 133-151
35. Sierra A, Lloveras B, Castellsague X, Moreno L, Garcia-Ramirez M and Fabra A (1995) Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 69: 54-60
36. Siziopikou KP, Prioleau JE, Harris JE and Schnitt SJ (1996) bcl-2 expression in the spectrum of preinvasive breast lesions. Cancer 77: 499-506
37. Solin LJ, Yeh IT, Kurtz J, Fourquet A, Recht A and Kuske R, McCormick B, Cross MA, Schultz DJ, Amalric R, Livolsi VA, Kowalyshyn MJ, Torhorst J, Jacquemier J, Westermann CD, Mazoujian G, Zafrani B, Rosen PP, Goodman RL and Fowble BL (1993) Ductal carcinoma in situ (intraduct carcinoma) of the breast treated with breast conserving surgery and definitive irradiation. Correlation of pathological parameters with outcome of treatment. Cancer 71: 2532-2542
38. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T and Van Dyke T (1994) p53-dependent apoptosis suppresses tumour growth and progression in vivo. Cell 78: 703-711
39. Tsuda H, Fukutomi and Hirobashi S (1995) Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade. Clin Cancer Res 1: 261-267
40. Van De Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio OA and Nusse R (1988) Neu protein overexpression in breast cancer: association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. New Engl J Med 319: 1239-1245
41. Weiss LM, Warnke RA, Sklar J and Cleary ML (1987) Molecular analysis of the t(14,18) chromosomal translocation an malignant lymphomas. New Engl J Med 317: 1185-1189